文献速递肝病消化道肿瘤与早癌

基于人工智能的肝纤维形态表型分析揭示代谢功能障碍相关脂肪性肝病的分子改变

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.
PubMed 文献 · Hepatology · 2025-04-22

研究对94例MASLD肝活检应用人工智能FibroNest算法量化纤维形态,识别出327种纤维表型并归纳为8个主成分(FibroPC1-8)。与全基因组转录组比较显示,FibroPC比组织学纤维化分期更敏感地捕捉MASLD相关分子改变,其中反映网状纤维的FibroPC4与预测MASLD发生肝细胞癌的基因特征相关。空间单细胞转录组揭示FibroPC4富集微环境中存在促癌肝星状细胞,其表型由衰老门周内皮细胞分泌的胰岛素样生长因子结合蛋白7诱导。

要点

  • FibroNest算法在94例MASLD肝活检中识别出327种纤维表型,归纳为8个主成分。
  • FibroPC比组织学纤维化分期更敏感地捕捉MASLD相关分子改变。
  • FibroPC4反映网状纤维,与预测MASLD发生肝细胞癌的基因特征相关。

核心结论

  • 肝脏形态学纤维表型分析可揭示MASLD的疾病进展和潜在机制。

研究设计与样本

  • 研究应用基于人工智能的FibroNest算法(PharmaNest)对94例MASLD肝活检进行纤维形态表型量化,其中12例(13%)合并肝细胞癌。
  • 通过配对肝样本的全基因组转录组比较评估形态纤维表型捕捉的分子改变,并使用空间单细胞转录组CosMx揭示驱动MASLD发病的细胞间相互作用,辅以体外实验验证。

主要发现

  • FibroNest识别出327种纤维表型,归纳为8个主要主成分,命名为FibroPC1-8。
  • 通路分析显示,与组织学纤维化分期相比,FibroPC更敏感地捕捉MASLD相关分子改变,如白细胞介素-6上调和resmetirom敏感性。
  • 反映网状纤维的FibroPC4与预测MASLD发生肝细胞癌的基因特征相关。
  • CosMx揭示FibroPC4富集微环境包含邻近门周内皮细胞的促肝细胞癌肝星状细胞。
  • 邻细胞分析提示肝星状细胞的促肝细胞癌表型由衰老门周内皮细胞分泌的胰岛素样生长因子结合蛋白7获得,体外实验显示胰岛素样生长因子结合蛋白7将肝星状细胞转化为促肝细胞癌表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Hepatic fiber morphology may significantly enhance our understanding of molecular alterations in metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to comprehensively characterize hepatic fiber morphological phenotypes in MASLD and their associated molecular alterations using multilayer omics analyses. APPROACH AND RESULTS: To quantify the morphological phenotypes of hepatic fibers, the artificial intelligence-based FibroNest algorithm (PharmaNest) was applied to 94 MASLD-affected liver biopsies, among which 12 (13%) had concurrent HCC. FibroNest identified 327 fiber phenotypes that were summarized into 8 major principal components, named FibroPC1-8. Next, molecular alterations captured by morphological fiber phenotypes were evaluated by comparison with genome-wide transcriptomics of paired liver samples. Pathway analyses revealed that FibroPCs more sensitively captured MASLD-related molecular alterations, such as upregulation of interleukin-6 and susceptibility to resmetirom, compared with the histological fibrosis stage. Among them, FibroPC4, which reflects reticular fibers, was associated with a gene signature predictive of incident HCC from MASLD. Furthermore, we used a spatial single-cell transcriptome, CosMx, to reveal the cell-cell interactions driving MASLD pathogenesis, as captured by FibroPC4. CosMx revealed that the FibroPC4-rich microenvironment contains HCC-promoting HSCs located adjacent to periportal endothelial cells. Neighboring cell analyses suggested that the HCC-promoting phenotype of HSCs was acquired by insulin growth factor-binding protein 7 secreted from senescent periportal endothelial cells. Consistently, in vitro experiments showed that insulin growth factor-binding protein 7 transformed HSCs into an HCC-promoting phenotype. CONCLUSIONS: Hepatic morphological fiber phenotyping can reveal the disease progression and underlying mechanisms of MASLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Fujiwara N, Matsushita Y, Tempaku M, et al. AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease. Hepatology. 2025. PMID: 40262132. doi:10.1097/HEP.0000000000001360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。